Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC)
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1
- 저널
- RADIOTHERAPY AND ONCOLOGY98(1) · pp.105 · 2011
- 피인용
- Web of Science 26
- JCR IF
- JCR 2010 4.337
- ISSN
- 0167-8140
저자
- 김성장제1저자교신저자Medical Research Institute, School of Medicine, Pusan National University, South Korea
- Kim, Yong-KiPrivate Clinic of Endocrinology and Metabolism and Nuclear Medicine, South Korea
- 김인주Medical Research Institute, School of Medicine, Pusan National University, South Korea
- 김영대Department of Thoracic and Cardiovascular Surgery, Pusan National University, South Korea
- 이민기Department of Internal Medicine, Pusan National University, South Korea
초록
Objective: The aim of the current study was to investigate the prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) NSCLC. Methods: A retrospective review identified 66 patients with surgically resected early (stage I & II) NSCLC who received dual time point F-18 FOG PET/CT at diagnosis of cancer. Survival analysis was conducted using Kaplan-Meier analysis, and survival curves stratified by age, sex, mediastinal lymph node involvement, TNM staging, SUVmaxE, SUVmaxD, and %Delta SUVmax were generated for estimation of overall survival and disease-free survival (DFS). Independent predictive factors for survival were determined using Cox proportional hazard model. Results: The overall survival and DFS were better in patients with tumor SUVmaxE <= 5.75 than the patients with tumor SUVmaxE >= 5.75. Seventeen patients (18.2%) with a tumor SUVmaxD >= 6.8 and 4 of 33 patients with tumor SUVmaxD <= 6.8 recurred during follow-up period. The median disease-free survival of the patients with tumor SUVmaxD >= 6.8 was 31.7 months and was significantly worse than the patients with tumor SUVmaxD <= 6.8 (Log rank test, X-2 = 10.45, p = 0.0012). The %Delta SUVmax did not have prognostic values for overall survival and disease-free survival. The SUVmaxE and SUVmaxD were the potent predictors for overall survival. Also, the potent predictor of DFS was the SUVmaxE. Conclusion: In conclusion, %Delta SUVmax measured by dual time point F-18 FDG PET/CT might not have a prognostic value for overall survival and DFS in surgically resected early stage (stage I & II) NSCLC. (C) 2010 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 98 (2011) 105-108
키워드
Dual time pointF-18 FDGNon-small cell lung cancerOverall survivalDisease-free survivalPOSITRON-EMISSION-TOMOGRAPHYPANCREATIC-CANCERNECK-CANCERRADIOTHERAPYRECURRENCESURVIVALHEADCT
식별자
- WoS UID
- 000286994400018



로그인
연구물 목록으로